Subtle Medical Inc, a medical imaging specialist and Stanford University spin-off, has reportedly raised close to USD 10 million in a Series B+ financing round. The financing was backed by investors including Shanghai-based Wenzhou Capital, Fusion Fund, ENVISIONX Capital, Bluerun Ventures, and other strategic partners across the Asia Pacific region. The funds will be directed towards the global commercialization efforts and research and development of the company’s products.
As a pioneer in leveraging generative artificial intelligence (AI) in healthcare, Subtle Medical boasts a robust pipeline of investigational products. Its AI product for image quality control, SubtleReformat, recently received marketing approval in the US. The company has recorded triple-digit growth in sales for three consecutive years and is projected to exceed global revenues of USD 100 million within the year.- Flcube.com
